Replies to post #16 on Harvard Bioscience Inc. (HBIO)

[surf1944]

7:14AM Harvard Biosci announces details of approved spin-off of Harvard Apparatus Regenerative Technology; co will distribute all of its shares of HART common stock on a pro rata basis to those stockholders that hold HBIO common stock at the close of business on Oct 21, 2013 (HBIO) 5.05 : The Board of Directors of Harvard Bioscience has approved the spin-off of its wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, or HART. To implement the spin-off distribution, Harvard Bioscience will distribute all of its shares of HART common stock on a pro rata basis to those stockholders that hold Harvard Bioscience common stock at the close of business on October 21, 2013, the Record Date for the distribution. Each such shareholder of Harvard Bioscience common stock will receive one share of HART common stock for every four shares of Harvard Bioscience common stock that such shareholder holds at the close of business on the Record Date. The distribution will be effective as of November 1, 2013. As a result of the spin-off, Harvard Bioscience will no longer own any shares of HART common stock and HART will be an independent public company. The dividend of HART common stock will be issued in book-entry form only, which means that no physical HART stock certificates will be issued